CROSS-PLATFORM CONCORDANCE ANALYSIS REVEALS ROBUST AND CLINICALLY RELEVANT GENE SIGNATURES IN BREAST CANCER
Abstract Background: Breast cancer is a molecularly heterogeneous disease characterized by diverse transcriptional programs across tumor subtypes. RNA sequencing (RNA-seq) has become a central tool for profiling these alterations; however, variability in data processing pipelines can introduce inconsistencies in downstream analyses, limiting the identification of robust and reproducible gene…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
